Equity Capital Markets
Taysha Gene Therapies
06/26
|
$230.0 Million
Âé¶¹´«Ã½ served as bookrunner for Taysha Gene Therapies on its June 2026 CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma